Half a million cases with serious side effects

The number of serious complications after vaccinations against Sars-CoV-2 is 40 times higher than that officially announced by the Paul Ehrlich Institute (PEI). This is one of the results of a long-term observational study carried out by the Berlin Charité, reports the public service MDR. The leader of the study is Professor Harald Matthes. He tells the MDR: “In view of around half a million cases with serious side effects after Covid vaccinations in Germany, we doctors must act.” Matthes is now calling contact points for those affected. Matthes: “We must come to therapeutic offers, discuss them openly at congresses and in public without being considered anti-vaccination.”

According to the study, eight out of 1,000 vaccinated people suffer from serious side effects. “Serious side effects” are symptoms that last for weeks or months and require medical treatment. Specifically, this includes inflammation of the heart muscle, overreactions of the immune system, or neurological disorders, i.e. deficiencies of the nervous system. “The number is not surprising,” says Matthes, the study’s leader. It corresponds to “what we know of other countries such as Sweden, Israel or Canada”. Even the manufacturers of the vaccines had already determined similar values ​​in their studies. Well-known manufacturers of Covid vaccines are companies such as Biontech, Moderna, Astrazeneca and Janssen.

Doctors often do not report suspected cases

Most side effects, including the most serious, would fade after “three to six months” and 80% would be cured. “But unfortunately there are also some that last much longer,” reports Professor Matthes. With conventional vaccines, such as those against poliomyelitis or measles, the number of serious side effects is “significantly lower”. It is particularly depressing for those affected that their complaints are “often not taken seriously”. Too often, liberal doctors do not associate the corresponding symptoms with vaccinations. Either they are not prepared for it, or “they do not want to position themselves in a fiery political atmosphere”.

The many letters addressed to the head of the study, Professor Matthes, in which the people concerned describe their “search for effective medical help and recognition, often lasting several months”, are also proof of this. continues the MDR report. The letters would show that “suspected cases are not officially reported”. Thus, “the number of serious reactions to vaccination at the Paul-Ehrlich-Institut with 0.2 reports per 1000 doses of vaccine is also significantly lower than in the Charité study”.

40,000 vaccinated people surveyed at regular intervals

The Charité and other clinics are currently developing effective treatments for people with vaccination complications. “The cause of the problem is often the presence of too many autoantibodies in the blood plasma of the people concerned,” explains Professor Matthes. Therefore, one must first determine “which and how many of these autoantibodies are present”. Laboratories that can perform the relevant tests must therefore also be “on board”. There are now structures capable of “carrying out at least the initial care of patients with vaccine complications”.

In the report, Matthes goes on to say, “Many of the known clinical pictures of ‘Long Covid’ match those that occur as side effects of vaccination.” It is now a question of opening up outpatient consultations to patients with complications from vaccination. Depending on the extent of the complication, patients could then be referred to specialist services such as neurology or cardiology. Intensive care units and dialysis centers could also be involved in the treatment.

The study “Covid-19 Vaccine Safety Profile” (ImpfSurv for short), which focuses on the effects and side effects of different vaccines, has been ongoing for a year. About 40,000 vaccinated people are surveyed at regular intervals throughout Germany. Participation in the study is voluntary. It takes place regardless of how the vaccines work in the respective subjects.

In addition to his work at the Berlin Charité, Harald Matthes, head of the study, sits on the board of directors of several specialist medical societies. He has been systematically reviewing the effects of drugs for many years.

Leave a Comment